These analyses yield novel insights into the role of NK cells in anti-CTLA-4 efficacy and represent a general strategy for the study of shared tumor biology across datasets derived from different tumor types, treatment groups, sequencing platforms, and species. Here, CTLA4 is linked to neoplasm.